Prenetics

company

About

Prenetics is a genetic and diagnostic health testing company that helps identify health risks with the use of a DNA sequencing technology.

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Wellness
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:PRE
Legal Name
Prenetics Limited

Prenetics is a genetic and diagnostic health testing company that helps identify health risks with the use of a DNA sequencing technology.

The startup company empowers individuals with valuable health information. It also offers a digital coaching app that provides people with a DNA profile that helps them adjust their diet. With a simple saliva sample, individuals can discover how their genes affect their diet, drug response, disease, and cancer risk. This information enables people to make health a choice, by living healthier and proactively preventing diseases. Prenetics operates its direct to consumer genomics business via its two brands, CircleDNA in Asia and DNAFit.

Danny Yeung, Lawrence Tzang, and Michael M. Yang headquartered Prenetics in Quarry Bay, Hong Kong Island in 2009.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$646.65M
Prenetics has raised a total of $646.65M in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Post-IPO Equity $120M 5 Detail
May 18, 2022 IPO $459M Detail
May 4, 2021 Series Unknown 1 Detail
Sep 17, 2020 Private Equity(PE) $15M 2 Apis Partners Detail
Oct 17, 2017 Series B $40M 4 Alibaba Entrepreneurs Fund
Beyond Ventures
Detail

Investors

Number of Lead Investors
Number of Investors
6
17
Prenetics is funded by 17 investors. Apis Partners and Beyond Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Apis Partners Yes Private Equity(PE)
Beyond Ventures Yes Series B
Ping An Yes Series A
Joel Neoh Yes Series A
Aspex Management Post-IPO Equity
Dragonstone Post-IPO Equity
Lippo Group Post-IPO Equity
PAG Post-IPO Equity
Xen Capital Post-IPO Equity
500 Global Series Unknown

Employee Profiles

Number of Employee Profiles
11
Prenetics has 11 current employee profiles, including Executive Danny Yeung
Executive
Executive
Employee
Executive
Executive

Acquisition

Prenetics has acquired 3 organizations. Their most recent acquisition was DNAFit on Apr 17, 2018. They acquired DNAFit for $10M.

Date Company Name
Industry Acquisition Type Price
Apr 17, 2018 DNAFit
Fitness acquisition $ 10M Detail
Jan 29, 2019 SOMA Analytics
Analytics acquisition Detail
Dec 16, 2022 ACT Genomics
Bioinformatics acquisition Detail